272 related articles for article (PubMed ID: 22843249)
1. Immunogenetics of the NKG2D ligand gene family.
Kasahara M; Yoshida S
Immunogenetics; 2012 Dec; 64(12):855-67. PubMed ID: 22843249
[TBL] [Abstract][Full Text] [Related]
2. Comparative genomics of the NKG2D ligand gene family.
Kasahara M; Sutoh Y
Immunol Rev; 2015 Sep; 267(1):72-87. PubMed ID: 26284472
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomic analysis of mammalian NKG2D ligand family genes provides insights into their origin and evolution.
Kondo M; Maruoka T; Otsuka N; Kasamatsu J; Fugo K; Hanzawa N; Kasahara M
Immunogenetics; 2010 Jul; 62(7):441-50. PubMed ID: 20376438
[TBL] [Abstract][Full Text] [Related]
4. MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA.
Kim Y; Born C; Bléry M; Steinle A
Front Immunol; 2020; 11():960. PubMed ID: 32582150
[TBL] [Abstract][Full Text] [Related]
5. Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4.
Zöller T; Wittenbrink M; Hoffmeister M; Steinle A
Front Immunol; 2018; 9():620. PubMed ID: 29651291
[TBL] [Abstract][Full Text] [Related]
6. The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.
Stojanovic A; Correia MP; Cerwenka A
Front Immunol; 2018; 9():827. PubMed ID: 29740438
[TBL] [Abstract][Full Text] [Related]
7. Genetics, genomics, and evolutionary biology of NKG2D ligands.
Carapito R; Bahram S
Immunol Rev; 2015 Sep; 267(1):88-116. PubMed ID: 26284473
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphism analysis of the NKG2D ligand cluster on the long arm of chromosome 6: Extensive polymorphisms and evidence of diversity between human populations.
Antoun A; Jobson S; Cook M; O'Callaghan CA; Moss P; Briggs DC
Hum Immunol; 2010 Jun; 71(6):610-20. PubMed ID: 20219610
[TBL] [Abstract][Full Text] [Related]
9. Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition.
Song DG; Ye Q; Santoro S; Fang C; Best A; Powell DJ
Hum Gene Ther; 2013 Mar; 24(3):295-305. PubMed ID: 23297870
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
11. MHC class I-like genes in cattle, MHCLA, with similarity to genes encoding NK cell stimulatory ligands.
Larson JH; Rebeiz MJ; Stiening CM; Windish RL; Beever JE; Lewin HA
Immunogenetics; 2003 Apr; 55(1):16-22. PubMed ID: 12679856
[TBL] [Abstract][Full Text] [Related]
12. CD8
Lerner EC; Woroniecka KI; D'Anniballe VM; Wilkinson DS; Mohan AA; Lorrey SJ; Waibl-Polania J; Wachsmuth LP; Miggelbrink AM; Jackson JD; Cui X; Raj JA; Tomaszewski WH; Cook SL; Sampson JH; Patel AP; Khasraw M; Gunn MD; Fecci PE
Nat Cancer; 2023 Sep; 4(9):1258-1272. PubMed ID: 37537301
[TBL] [Abstract][Full Text] [Related]
13. The Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D Ligands.
Zuo J; Mohammed F; Moss P
Front Immunol; 2018; 9():1820. PubMed ID: 30166984
[TBL] [Abstract][Full Text] [Related]
14. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
[TBL] [Abstract][Full Text] [Related]
15. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.
Wittenbrink M; Spreu J; Steinle A
Eur J Immunol; 2009 Jun; 39(6):1642-51. PubMed ID: 19424970
[TBL] [Abstract][Full Text] [Related]
16. Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells.
Zingoni A; Cecere F; Vulpis E; Fionda C; Molfetta R; Soriani A; Petrucci MT; Ricciardi MR; Fuerst D; Amendola MG; Mytilineos J; Cerboni C; Paolini R; Cippitelli M; Santoni A
J Immunol; 2015 Jul; 195(2):736-48. PubMed ID: 26071561
[TBL] [Abstract][Full Text] [Related]
17. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia.
Salih HR; Antropius H; Gieseke F; Lutz SZ; Kanz L; Rammensee HG; Steinle A
Blood; 2003 Aug; 102(4):1389-96. PubMed ID: 12714493
[TBL] [Abstract][Full Text] [Related]
18. Expression of stress ligands of the immunoreceptor NKG2D in melanoma: regulation and clinical significance.
Paschen A; Baingo J; Schadendorf D
Eur J Cell Biol; 2014; 93(1-2):49-54. PubMed ID: 24629838
[TBL] [Abstract][Full Text] [Related]
19. Murine NKG2D ligands: "double, double toil and trouble".
Samarakoon A; Chu H; Malarkannan S
Mol Immunol; 2009 Mar; 46(6):1011-9. PubMed ID: 19081632
[TBL] [Abstract][Full Text] [Related]
20. Expressional regulation of NKG2DLs is associated with the tumor development and shortened overall survival in lung adenocarcinoma.
Kucuk B; Cacan E
Immunobiology; 2022 Jul; 227(4):152239. PubMed ID: 35780757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
